Compare PSQH & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSQH | CCEL |
|---|---|---|
| Founded | 2021 | 1989 |
| Country | United States | United States |
| Employees | 85 | N/A |
| Industry | Advertising | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9M | 32.7M |
| IPO Year | N/A | 2022 |
| Metric | PSQH | CCEL |
|---|---|---|
| Price | $0.62 | $3.32 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 293.5K | 8.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.49 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $0.60 | $3.10 |
| 52 Week High | $2.88 | $6.99 |
| Indicator | PSQH | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 34.94 | 34.42 |
| Support Level | N/A | $3.19 |
| Resistance Level | $0.83 | $3.57 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 8.88 | 5.56 |
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.